» Articles » PMID: 36697572

Mass Spectrometric Based Detection of Protein Nucleotidylation in the RNA Polymerase of SARS-CoV-2

Overview
Journal Commun Chem
Publisher Springer Nature
Specialty Chemistry
Date 2023 Jan 25
PMID 36697572
Authors
Affiliations
Soon will be listed here.
Abstract

Coronaviruses, like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), encode a nucleotidyl transferase in the N-terminal (NiRAN) domain of the nonstructural protein (nsp) 12 protein within the RNA dependent RNA polymerase. Here we show the detection of guanosine monophosphate (GMP) and uridine monophosphate-modified amino acids in nidovirus proteins using heavy isotope-assisted mass spectrometry (MS) and MS/MS peptide sequencing. We identified lysine-143 in the equine arteritis virus (EAV) protein, nsp7, as a primary site of in vitro GMP attachment via a phosphoramide bond. In SARS-CoV-2 replicase proteins, we demonstrate nsp12-mediated nucleotidylation of nsp7 lysine-2. Our results demonstrate new strategies for detecting GMP-peptide linkages that can be adapted for higher throughput screening using mass spectrometric technologies. These data are expected to be important for a rapid and timely characterization of a new enzymatic activity in SARS-CoV-2 that may be an attractive drug target aimed at limiting viral replication in infected patients.

References
1.
Polack F, Thomas S, Kitchin N, Absalon J, Gurtman A, Lockhart S . Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383(27):2603-2615. PMC: 7745181. DOI: 10.1056/NEJMoa2034577. View

2.
Arts E, Hazuda D . HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012; 2(4):a007161. PMC: 3312400. DOI: 10.1101/cshperspect.a007161. View

3.
Bekker L, Tatoud R, Dabis F, Feinberg M, Kaleebu P, Marovich M . The complex challenges of HIV vaccine development require renewed and expanded global commitment. Lancet. 2019; 395(10221):384-388. DOI: 10.1016/S0140-6736(19)32682-0. View

4.
Falade-Nwulia O, Suarez-Cuervo C, Nelson D, Fried M, Segal J, Sulkowski M . Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. Ann Intern Med. 2017; 166(9):637-648. PMC: 5486987. DOI: 10.7326/M16-2575. View

5.
Scott N, Wilson D, Thompson A, Barnes E, El-Sayed M, Benzaken A . The case for a universal hepatitis C vaccine to achieve hepatitis C elimination. BMC Med. 2019; 17(1):175. PMC: 6749704. DOI: 10.1186/s12916-019-1411-9. View